NeueHealth, Inc. (NYSE:NEUE) Short Interest Update

NeueHealth, Inc. (NYSE:NEUE) was the target of a large decrease in short interest in the month of February. As of February 28th, there was short interest totalling 9,200 shares, a decrease of 25.8% from the February 13th total of 12,400 shares. Currently, 0.3% of the company’s shares are short sold. Based on an average daily volume of 38,400 shares, the days-to-cover ratio is presently 0.2 days.

NeueHealth Stock Down 7.4 %

NEUE traded down $0.38 during trading on Monday, hitting $4.71. 81,052 shares of the company’s stock were exchanged, compared to its average volume of 18,693. The stock has a market cap of $38.98 million, a P/E ratio of -0.09 and a beta of 0.56. The business’s 50 day moving average is $7.21 and its two-hundred day moving average is $6.01. NeueHealth has a fifty-two week low of $3.79 and a fifty-two week high of $7.66.

Insider Buying and Selling at NeueHealth

In other news, CEO George Lawrence Mikan III sold 12,440 shares of the firm’s stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $6.13, for a total transaction of $76,257.20. Following the completion of the sale, the chief executive officer now owns 249,454 shares of the company’s stock, valued at $1,529,153.02. This trade represents a 4.75 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Jay Matushak sold 4,448 shares of the firm’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $6.74, for a total transaction of $29,979.52. Following the sale, the chief financial officer now directly owns 41,592 shares of the company’s stock, valued at approximately $280,330.08. This trade represents a 9.66 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 126,836 shares of company stock valued at $844,797. 64.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On NeueHealth

Hedge funds and other institutional investors have recently made changes to their positions in the business. Virtu Financial LLC bought a new stake in shares of NeueHealth during the fourth quarter worth about $76,000. Northern Trust Corp increased its position in shares of NeueHealth by 66.8% during the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock worth $242,000 after acquiring an additional 13,074 shares in the last quarter. Finally, Partners Group Holding AG bought a new stake in shares of NeueHealth during the third quarter worth about $463,000. 63.88% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, Royal Bank of Canada reduced their price objective on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a research report on Monday, December 9th.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.